Efficacy of toltrazuril in the prevention of coccidiosis in naturally infected lambs on pasture

The efficacy of toltrazuril (Bay Vi 9142) in preventing ovine coccidiosis due to an infection acquired immediately after turnout on pasture was evaluated by comparing the faecal consistency, weight gain, and oocyst output of treated and untreated lambs in 3 trials. The lambs were either given a single treatment with toltrazuril at 15 or 20 mg/kg, or they were given a dose of 10 mg/kg on 2 separate days. A single treatment with toltrazuril at 20 mg/kg on day 10 after turnout on pasture almost completely prevented coccidiosis in 2 trials. In a third trial the acute phase of a severe Nematodirus battus infection coincided with the outbreak of coccidiosis, and thus partly masked the clinical effect of the anticoccidial treatment. In lambs treated with toltrazuril at 15 mg/kg on day 10 after turnout, the coccidial infection caused a softening of the faeces, but the lambs were not severely affected by the coccidia. In lambs given a dose of 10 mg/kg of toltrazuril twice, either on days 10 and 11 after turnout, or on days 10 and 20, the coccidial infection caused a softening af the faeces, including some cases of diarrhoea. Oocyst production due to the initial coccidial infection on pasture was markedly reduced by all treatments with toltrazuril. The reduction was most pronounced after a dose of 20 mg/kg. Lambs treated with single doses of 15 or 20 mg/kg of toltrazuril had a better weight gain than the untreated controls in 2 of the trials. Lambs treated with toltrazuril on day 10 after turnout were partially resistant to the coccidial reinfection acquired immediately after treatment, and they had a similar level of immunity as the untreated controls to the subsequent reinfection on pasture.     

Treatment with toltrazuril in a natural outbreak of coccidiosis in calves

Treatment with toltrazuril (Baycox) in calves naturally infected with several enteropathogenic agents resulted in a reduction in the mean number of Eimeria oocysts shed. The mean faecal consistency for the treated calves also differed significantly from that of the untreated calves. There was virtually no difference in weight gain in the two groups.     

阿德呋啉水溶剂治疗鸡球虫病的试验研究

为了观察阿德呋啉水溶剂治疗艾美耳球虫的效果,试验设5个药物试验组、阳性及阴性对照组。70只13日龄的雏鸡随机分为7组,其中药物试验组鸡只开始给药。给药24 h后,除阴性对照组外,其余组鸡只均接种混合的球虫孢子化卵囊(5万/羽),试验后根据抗球虫指数(ACI)判断抗球虫药的疗效。结果显示所有给药组中65 mg/kg阿德呋啉水溶剂组ACI为185.54,抗球虫效果最好,为高效抗球虫药;其余阿德呋啉试验组ACI均低于180,浓度过高抗球虫效果差;妥曲珠利试验组ACI低于120,为低效抗球虫药。试验得到了最佳的使用浓度,为球虫病的防治提供了方法。     

Sulfonamide and toltrazuril therapy of experimental turkey coccidiosis

Following experimental infection of caged turkeys with a mixed oocyst suspension of E. meleagrimitis, E. adenoeides and E. gallopavonis, the efficacy of sulfachlorpyrazine, sulfaquinoxaline + pyrimethamine, sulfaquinoxaline + diaveridine, and toltrazuril was investigated based on clinical and parasitological parameters. Infected turkeys developed severe clinical symptoms. Only weak symptoms were observed in those groups which were treated with the sulfa- and sulfa-DHFR-inhibitors. The toltrazuril-treated group remained free of clinical symptoms. At the 8th day after infection, the clinical lesions coincided with the intensity of the gut lesions together with parasitological findings based on microscopical examination of mucosal smears. The same coincidence was observed for parameters such as oocyst excretion and body weight development.     

Efficacy of toltrazuril against intestinal and hepatic coccidiosis in rabbits

The anticoccidial effect of toltrazuril (Bay Vi 9142) against Eimeria flavescens, E. intestinalis, E. magna, E. perforans and E. stiedai was tested in experimentally-infected rabbits. Continuous administration of 10-15 p.p.m. of the drug in the drinking water was highly effective in reducing oocyst output of all five species and in preventing clinical signs and macroscopic lesions. Sporulation of excreted oocysts was not affected. After 5 weeks of medication, no negative influence was noted on zootechnic performance of growing healthy rabbits. Medication of rabbits with 25 p.p.m. only during schizogony or gamogony (2 days of treatment, repeated after 5 days) quickly reduced clinical signs and oocyst output. When administered during late schizogony or gamogony, toltrazuril allowed development of immunity against reinfection with homologous species.     

Administration of toltrazuril during experimental coccidiosis in mule ducks: comparison of the efficacy of a single administration at two different endogenous stages

An experimental Eimeria mulardi coccidiosis was reproduced in mule ducks. A single dose of toltrazuril (7 mg per kg) was administered at two different endogenous stages: Day 2 (first meronts) or Day 5 (last meronts and gamonts). The efficacy of the drug was assessed on four criteria (body weight, oocyst counts, macroscopic lesions, and presence of the meronts and gamonts). To have a curative effect, a single dose of toltrazuril should be administered early on. However, a single treatment on Day 5 had a prophylactic effect.     

The use of toltrazuril for the prevention of coccidiosis in piglets before weaning

SUMMARY: To determine the efficacy of toltrazuril as a prophylactic treatment for coccidiosis in piglets caused by Isospora suis (I suis) , a single 1.0 mL dose of toltrazuril was administered orally to 1056 piglets between 3 and 6 days of age, in 5 piggeries. Prophylactic treatment of piglets reduced the occurrence of coccidiosis in litters from 71% to 22%. The number of antibacterial treatments given and the number of piglets affected per litter were also significantly reduced, resulting in some improvement in growth rates to weaning. The severity of diarrhoea was significantly reduced, as was the amount of oocyst excretion. The number of days that piglets excreted oocysts in the faeces was reduced from 4.9 days to 2.5 days. The detection of J suis in piglets with diarrhoea was reduced from 84% in the untreated piglets to 6% in the piglets given the prophylactic treatment.     

Specific immunoglobulins in serum of newborn lambs fed with a single dose of colostrum containing anti-peroxidase IgG

The apparent efficiency of absorption and the decrease of specific colostral IgG after its passage into the blood stream were determined in newborn lambs fed with a single dose of colostrum containing anti-peroxidase IgG at 30 minutes, 12 hours and 24 hours after birth. When colostrum was given at 30 minutes after birth, a value of 16.9+/-4.0 per cent of anti-peroxidase IgG ingested appeared in lamb circulation. This percentage was reduced to 9.8+/-0.8 per cent when the feeding was done at 12 hours after birth and no specific IgG was detected in lambs fed at 24 hours after birth. The concentration of anti-peroxidase IgG in lambs' serum declined quickly within 96 hours of age to about 48 per cent of the initial value, and afterwards the level decreased slowly reaching a value of 10 per cent at 32 days of age. This behaviour probably reflects the protein distribution and use of absorbed antiperoxidase IgG.     

Pharmacokinetics of rifampin given as a single oral dose in foals

Six foals from 6 to 8 weeks of age were given a single oral dose of rifampin at a dosage of 10 mg/kg of body weight. Serum rifampin concentrations were measured serially during a 24-hour period. The mean peak serum rifampin concentration was 6.7 micrograms/ml at 4 hours after treatment. The concentration decreased slowly, and at 24 hours the mean value was 2.7 micrograms/ml. The elimination half-life was 17.5 hours, and the elimination rate constant was 0.04/hr.     

Neurotoxicity induced by a single oral dose of aniline in rats.

The neurotoxicity of aniline and its age-dependent responses were investigated in male rats. Groups of 6 rats, 4-week-old, were treated once with aniline (500, 750 or 1,000 mg/kg) or olive oil by gavage. Additional groups of 6 rats, 7- or 10-week-old, were treated once with 800 mg/kg of aniline or olive oil. Paralytic gait or hindlimb paralysis was observed between post-treatment days 8 and 15 in two out of six rats receiving 1,000 mg/kg of aniline at 4 weeks of age. On post-treatment day 15, spongy change in the white matter of the spinal cord was observed in all rats receiving 750 or 1,000 mg/kg of aniline at 4 weeks of age. The lateral and ventral columns of the thoracic spinal cord were the most severely affected. Spongy change in the facial nerve and spinal trigeminal tracts of pons and medulla oblongata, and mild degeneration of the peripheral nerves was found in 3 out of 6 rats receiving 1,000 mg/kg of aniline. At the ultrastructural level, the spongy change was due to distention of the myelin sheath and splitting of the intraperiod line. Axons were well preserved in the affected nerve fibers. No abnormalities were seen in the neuronal cell bodies. Although transient cyanosis was observed in all rats receiving 800 mg/kg of aniline at 7- or 10-week-old, as well as in rats receiving 750 or 1,000 mg/kg of aniline at 4-week-old, no treatment-related neurobehavioral or morphologic abnormalities were found in the former. These findings demonstrate the neurotoxicity of orally administered aniline for rats, depending upon the age of the animal at the time of administration.     

Efficacy of a single dose of oral antibiotic given within two hours of birth in preventing watery mouth disease and illthrift in colostrum-deficient lambs.

An antibiotic with a product licence limited to the treatment and control of infectious bacterial enteritis associated with Escherichia coli in piglets was tested for its ability to control watery mouth disease in neonatal lambs. Three groups of lambs were kept in conditions commonly encountered in intensive lambing systems, where high levels of environmental bacterial contamination may be expected. They were allocated at birth to: a control group (group 1) consisting of 18 colostrum-deprived lambs; group 2, consisting of 17 lambs given one feed of colostrum when they were two hours old; and group 3, consisting of 18 colostrum-deprived lambs given spectinomycin orally when they were two hours old. Nine group 1 lambs became diseased and were killed for humane reasons. Blood biochemical changes included hyperglycaemia followed by hypoglycaemia, lactacidaemia, hypoproteinaemia and metabolic acidosis, and postmortem examination of the diseased lambs showed signs consistent with endotoxaemia and a clinical diagnosis of watery mouth disease. Coliforms were isolated from the blood of all group 1 lambs and from half the lambs in groups 2 and 3, but endotoxaemia and watery mouth disease occurred only in group 1 lambs. The results for groups 2 and 3 showed that neither colostrum nor antibiotic at the rates and frequency used prevented bacteraemia, although consecutive samples were positive only on three occasions. Group 3 lambs consistently grew more rapidly than the surviving group 1 lambs and as rapidly as group 2 lambs. There was no evidence that male lambs were more prone to watery mouth disease than female lambs. The results indicated that the antibiotic spectinomycin did not induce endotoxaemia during low-grade bacteraemia and that a single oral dose given within two hours of birth protected colostrum-deprived lambs delivered into a contaminated indoor environment against watery mouth disease.     

Enrofloxacin assay validation and pharmacokinetics following a single oral dose in chickens

The pharmacokinetics of enrofloxacin (ENRO), a fluoroquinolone antimicrobial agent, was studied in male broiler chickens (Cobb) after single oral administration of 10 mg of ENRO/kg b.w. A high-performance liquid chromatography-photodiode array detector (DAD) (HPLC-DAD) method was developed and validated and used for quantitation of ENRO and its major metabolite ciprofloxacin in plasma. The HPLC analyses were carried out using a cationic-octadecyl mixed column and 0.05 mol/L phosphate buffer (pH 2.5)/acetonitrile as mobile phase. The sample preparation of plasma consisted of the precipitation of proteins followed by solid phase extraction on cationic-octadecyl mixed cartridges. The method was validated considering linear range, linearity, selectivity, sensitivity, limit of detection (LOD), limit of quantitation (LOQ), intra- and inter-day precisions and accuracy. The LOD and LOQ for both fluoroquinolones were 60 and 200 ng/mL for plasma. The plasma concentration vs. time graph was characteristic of a two-compartment open model. The maximal plasma concentration of 1.5 +/- 0.2 mg/mL was achieved at 9 +/- 2 h. The elimination half-life and the mean residence time of ENRO were 1.5 +/- 0.2 and 15.64 h, respectively. The area under the concentration-time curve was calculated as 35 +/- 4 mgxh/mL.